Format

Send to

Choose Destination
See comment in PubMed Commons below
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:261-7. doi: 10.1016/j.pnpbp.2013.10.018. Epub 2013 Nov 2.

Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants.

Author information

1
Department of Pharmacology, National University of Ireland, Galway, Ireland; European Graduate School for Neuroscience, Department of Psychiatry and Neuropsychology, Maastrict University, The Netherlands. Electronic address: belucg@iol.ie.

Abstract

This review summarises the evidence that chronic low grade inflammation plays an important role in the pathology of depression. Evidence is provided that pro-inflammatory cytokines, together with dysfunctional endocrine and neurotransmitter systems, provide a network of changes that underlie depression and may ultimately contribute to the neurodegenerative changes that characterise depression in the elderly. Antidepressants attenuate the inflammatory changes and hypercortisolaemia by reducing the release of the pro-inflammatory cytokines from activated microglia, and by sensitizing the glucocorticoids receptors in the HPA axis. These effects correlate with an improvement in monoamine neurotransmitter function. The possible mechanisms whereby this cascade of changes occurs are outlined. In conclusion, the mechanisms whereby antidepressants act should now consider the involvement of the immune and endocrine systems in addition to the central neurotransmitters. This may open up possibilities for a new generation of antidepressants in the future.

KEYWORDS:

Antidepressants; Cytokines; Depression; Inflammation

PMID:
24189118
DOI:
10.1016/j.pnpbp.2013.10.018
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center